Antimicrobial resistance is becoming a major threat to public health throughout the world. Researchers from around the world are attempting to contrast it by developing both new antibiotics and patientspecific treatments. It is, therefore, necessary to study these treatments, via phenotypic tests, and it is essential to have robust methods available to analyze the resistance patterns to medication, which could be applied to both new treatments and to new phenotypic tests. A general method is here proposed to study minimal inhibitory concentration (MIC) distributions and fixed breakpoints in order to separate sensible from resistant strains. The method has been applied to a new 96-well microtiter plate.
and more concerned about antimicrobial resistance (AMR), due to the reduced ability of standard compounds to treat infectious diseases WHO (2017) ; European Commission (2017); Gelband et al. (2015) .
Antimicrobial resistance mechanisms have been observed in bacteria Tenover (2006) ; Zignol et al. (2006) ; Kohanski et al. (2010) Methods used to tackle the rise in AMR include a wiser prescription of antimicrobials, in order to develop patient-specific treatments that take into account known resistance patterns. Such patterns are studied through antimicrobial susceptibility testing (AST) to identify at which concentration of a particular drug the growth of the pathogen is inhibited. In this respect, microtiter plates allow the effectiveness of several drugs to be tested at the same time on a single clinical isolate.
Traditionally, AST methods generally rely on the definition of critical concentrations (CC), i.e. values used to differentiate between resistant and sensitive isolates which are specific to the antimicrobial agent and to the test method.
Antimicrobial data, obtained through dilution methods Wiegand et al. (2008) are registered as minimum inhibitory concentration (MIC) values, expressed in milligrams per litre (mg/l). MIC is defined as the minimal concentration of an antimicrobial substance that inhibits the visual growth of a pathogen after incubation. Since this type of test is more accurate than diffusion tests, MICs are considered the golden standard of susceptibility tests Turnidge and Paterson (2007) . Ac-cording to the experiment design adopted to obtain MIC values, the data of a specific drug is usually obtained in the form of a distribution.
In this paper, MIC values obtained from dilution experiments on a 96-well microtiter plate containing a liquid growth medium (broth) are analyzed, where the same dose of pathogen is cultured in each well, but in the presence of successively increasing antimicrobial concentrations. The MIC value is identified as the concentration of the first well which does not allow pathogen to grow. By convention, if no growth is observed in any well, the MIC is set to the lowest concentration available and, if growth is inhibited at each concentration level, the MIC is set to an agreed higher level of antimicrobial concentration that has not studied on the plate.
To the best of the author's knowledge, neither clinical breakpoints nor epidemiological cutoffs have been defined for any microtiter plate.
The aim of this work is to propose and compare statistical methods in order to define such thresholds.
Although the methods presented in this paper may be applied to any pathogen and any dilution method, the attention has been focused on M. Tuberculosis, given the importance of the resistance mechanisms developed by this pathogen. There is proof that the trend of the new cases of tuberculosis is decreasing Dheda et al. (2017) , but the number of cases resistant to one or more drugs, in particular to first-line drugs (rifampicin, ethambutol, isoniazid and pyrazinamide) is increasing WHO (2015) ; Falzon et al. (2015) . There are two main causes of the development of drug resistance, that is, either the prescription of suboptimal treatments or direct transmission.
The detection of resistance in microbiology laboratories is expected to become faster and less expensive in order to provide essential guidance to define more tailored and effective treatment schemes, and the identification of thresholds to discriminate resistant from sensitive isolates is essential. The critical concentrations of most of the anti-TB drugs have been recently revised and updated by the World Health Organisation WHO (2018), through an extensive study of the literature, and it has emerged that the identification of critical concentrations is not a simple task, as is usually assumed. However, the identification of critical concentrations is an essential step for any subsequent analysis; for instance, it could be important, in genome-wide association studies Hirschhorn and Daly (2005) , to define phenotypic subgroups in order to identify the mutations associated with specific levels of resistance more clearly, in particular for those antimicrobials for which only a few resistant cases are observed (for example, when studying bedaquiline which is a new treatment for tuberculosis): in these cases, a GWAS study would describe a "wild-type" structure rather than genomic features associated with resistance.
Establishing a reliable phenotypic labeling of resistance during drug susceptibility tests is an essential step to develop reliable testing methods and to perform analysis on the identification of resistant mutations. As part of the project, the CRyPTIC Consortium have designed a UKMYC5 96-well microtiter plate. The plate has been tested by seven laboratories in Asia, Europe, South America and Africa by using 19 external quality assessment (EQA) strains, including the most studied strain of tuberculosis, H37Rv. Samples vere inoculated either 2 or 10 times and each plate was then incubated for 21 days. Two researchers from each laboratory were asked to independently identify the MIC values for each plate at four moments after incubation (day 7, day 10, day 14 and day 21) with three reading methods: Vizion imaging system, a mirrored box and an inverted-light microscope. A full description of the experiment and of the results in terms of reproducibility of the plate are available in Rancoita et al. (2018) . Since the authors identified the highest level of reproducibility for readings at it will be discarded in the following of the CRyPTIC study. For these reason, the outcome relative to PAS will be presented in this work, but considered more uncertain.
Notice that, as already stated, the isolates analysed in the study were subcultured several times, therefore there are repeated observations for the same sample, feature that will be considered in the model we will present. the cutoffs is a reasonable upper limit of the wild-type distribution.
More sophisticated statistical methods based on the analysis of wildtype isolates only are also available (Jaspers et al., 2014).
The empirical distributions described in Figure 1 show that the MIC values have a complex structure and standard models does not seem to appropriately fit the data. Different from the "local" methods, the "global" methods aim at modelling the whole mixing distribution (Jaspers et al., 2016) : the identification of epidemiological cutoffs become a model-based classification problem. We propose to use an approach based on mixture models. These are very flexible tools used in various scientific areas, which can be used to tackle either clustering or density estimation problems. The reasons to fit a Bayesian mixture model is motivated by two aspects. First, it seems more appropriate to model the whole mixing structure rather than only the wild-type group of isolates, since the classification is unsupervised and the microtiter plates under study are characterized by biological noisiness; moreover, there exist overlapping areas in the distributions which could not be appropriately classified. The standard way to define a wild-type group is by looking at those isolates with no known conferring-resistance mutations. However, the complete pat- 
where f k (·)'s are the component probability distributions of the mixture and π k 's are known as mixture weights and are such that 0 ≤ π k ≤ 1 and
are free to come from any family (and they can also model either discrete or continuous random variables), in many applications it is usually assumed that all the distributions in the mixture come from the same family denoted by different parameters.
The number of component K is, in general, unknown and can be considered both unknown but finite (finite mixture models) or infinite (nonparametric mixtures). We refer the reader to Titterington et al. The model-based classification separates the isolates in the wildtype subgroup when
Here, the estimation of the MIC distributions is instrumental to establish cuttofs to classify the isolates into levels of resistance to the antimicrobials. It has to be briefly noted that mixture models can also be used in the general setting of density estimation, where the underlying separation in subgroups has not necessarily a biological meaning;
for example, if we consider susceptibility/resistance as a gradual and continuous scale with no clear distinction between two groups, mixture models can still be used to estimate the MIC distribution.
There exist several proposals in the literature to model the MIC distributions through mixture models. The most famous is using mix- 
The proposed models
We decide to implement a Bayesian analysis (Robert, 2007) , so to have posterior distributions (and relative credible intervals) of all the parameters involved in the model. As part of the analysis, it is necessary to define prior distributions for all the parameters in the model, describing the prior knowledge the experimenter has about them. We have decided to use the default prior proposed in Grazian et al. (2018) for the number of components since it has been shown to have a good balance between conservativeness and accuracy and standard vague priors for the rest of the parameters as in Richardson and Green (1997) , in order to reduce the influence of the prior on the posterior distribution. Bayesian estimation of mixture models is a non-standard problem, therefore Monte Carlo Markov chains (MCMC) methods are needed to approximate the posterior distribution (Robert and Casella, 2013) .
Define a family of random distributions F = (F x , x ∈ X ), indexed by a categorical covariate x, which may be a vector: 
Mixture of Gaussian distributions
First, we assume a Gaussian mixture model for the MIC values
where µ k and σ 2 k are the mean and the variance of the k-th component respectively and y i = y xi .
Since each strain has been subcultured several times, the MIC value related to each strain has been identified on several plates, see Table 2 . Therefore, the distribution g(·) depends on the set of covariates x, specifying the tested compound and strain. In particular, we assume that
where a d,k is an intercept specific to the tested compound and b s,d,k is
an intercept specific to the tested strain with respect to compound d.
Equation 4 shows that a mixture model can be interpreted in a missing data framework: one could suppose the existence of a latent variable Z i taking the values in {1, . . . , K} with probabilities {π 1 , . . . , π K } and labelling the component to which the observation belongs; in other words, the conditional density of
) is distributed according to a multinomial distribution. This latent variable representation is useful for increase the computational efficiency of MCMC algorithms (Diebolt and Robert, 1994 ).
This approach is extremely flexible, since it considers both the possibility that there are more than two subgroups in the data, by allowing to consider intermediate levels of resistance, and the possibility that the data are not exactly distributed as Gaussian variables:
in particular, the "non-wild-type" component may be defined as a convolution of Gaussian distributions itself.
Gaussian latent representation through mixture models
Although the previously proposed approach is very flexible, it does not take into account the censored nature of the data: MIC values are not actually continuous, they are rounded to the next two-fold dilution.
Moreover, the data are essentially truncated to the minimum and to the maximum dilution chosen for the plate.
It is, then, possible to consider a mixture of distributions, where the discrete nature of the data is taken into account by rounding continuous (for instance, Gaussian) distributions. We introduce a latent variable Y * ∈ R which is related to the observed variable Y representing the registered MIC value, so that:
i.e. the observed y i assumes values in the set of the dilutions chosen for the drug d depending on a Gaussian latent variable y * i which can take value out of the set of the dilutions and which has the distribution described in Equation (3). Given a set of values representing the different
. . , +∞}, the probability mass function p for y is defined as
where y * is assumed to follow the distribution given in (3). This approach may be seen as a latent Gaussian representation, along the line of Albert and Chib (1993) . The mixing nature of the data is transferred to an implicit and richer variable which is censored and then observed only at a discrete scale.
There exist several approaches which generalize the algorithm proposed by Albert and Chib (1993) It is straightforward to define the corresponding Gibbs-sampler algorithm, which is described in Figure 2 :
• Step 1: Generate y * i from the full conditional distributions:
Step 2: Update K
•
Step 3: Update the latent variable Z i following a multinomial distribution with probabilities
•
Step 4:
Step 4a: Update µ -Step 4a: Update σ 2
Applications
The methods proposed in Section 3 is now applied to the dataset described in Section 1. The goal of the analysis is to estimate the distributions of the MIC values for each of the drugs evaluated on the microtiter plate and to identify breakpoints for the plate itself. The estimated method is based on MCMC simulations, and the evaluation of the convergence is available in the Supporting Information.
The ECOFFs identified with the censored Gaussian mixture model have been compared with three other methods: the critical concen- an interesting property of the proposed method is that it is possible to deal with both interval censoring (related to the fact that the observations are registered at fixed dilutions) and censoring at the bounds (related to the fact that a minimal and a maximal dilution are chosen to test the isolates): the means of the components can be estimated out of the plate observational range.
Several comments can be made from an observation of Table 3 . It is evident that the correct choice of the level of the quantile is essential to identify a reasonable ECOFF, and it may be changed according to the drug. However, it is a priori difficult to fix this level. There are drugs which clearly show a not-bimodal distribution, EMB, ETH and LZD in particular. The CRyPTIC consortium decided to change the concentrations considered in the study for these compounds, and in this way ECOFFs will be identified better in the future.
As already mentioned, PAS does not seem to have a recognisable distribution either, and it was removed from the study, therefore the identified ECOFF should be considered with caution.
The censored GMM and the cumulative distribution approach with a quantile of level 0.90 seems to produce similar results for the other drugs. However, the second approach is more conservative and tends to fix the critical concentrations at a lower level. The probability of identifying all the isolates that show mutations known to confer resistance to the specific drug as non-wild-type is higher for the cumulative distribution approach (Table S2 in the Supplementary Information), although it is similar to that obtained with the censored GMM for most of the cases. Nevertheless, the probability of identifying the isolates that show no mutation conferring resistance as sensitive (Table S3 in the Supplementary Information) is higher for the censored GMM. This shows that the choice of the method that should be used 
Conclusions
A general method has been proposed to approximate MIC distributions and identify critical concentrations. This method may be applied to several testing situations and in the presence or absence of repeated show that the proposed approach leads to the highest combination of sensitivity and specificity for all of the considered drugs, as far as the known genomic patterns of resistance are concerned.
At the moment, the dataset is somewhat limited. However this is just the first attempt to define ECOFFs for the microtiter plate used in the CRyPTIC project. As long as more data are collected and more genomic mutations related to resistance will be identified, the calibration of the breakpoints will be improved. -------Appendix 4: Genotype of the strains 
